Yasmin and Quincke's disease - a phase IV clinical study of FDA data

Summary:

Quincke's disease is reported only by a few people who take Yasmin.

The phase IV clinical study analyzes which people take Yasmin and have Quincke's disease. It is created by eHealthMe based on reports of 47,549 people who have side effects while taking Yasmin from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 26, 2023

47,549 people reported to have side effects when taking Yasmin.
Among them, 4 people (0.01%) have Quincke's disease.

What is Yasmin?

Yasmin has active ingredients of drospirenone; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 48,555 Yasmin users for its effectiveness, alternative drugs and more.

What is Quincke's disease?

Quincke's disease (a form of localized swelling of the deeper layers of the skin and fatty tissues beneath the skin) is found to be associated with 963 drugs and 479 conditions by eHealthMe.

Number of Yasmin and Quincke's disease reports submitted per year:

Time on Yasmin when people have Quincke's disease *:

Gender of people who have Quincke's disease when taking Yasmin *:

female: 75 %
male: 25 %

Age of people who have Quincke's disease when taking Yasmin *:

Common drugs people take besides Yasmin *:

Common side effects people have besides Quincke's disease *:

Nausea And Vomiting: 2 people, 50.00%
Nausea (feeling of having an urge to vomit): 2 people, 50.00%
Infusion Related Reaction: 2 people, 50.00%
Angioedema (rapid swelling of the dermis): 2 people, 50.00%
Skin Blushing/flushing (a sudden reddening of the face, neck): 1 person, 25.00%
Indigestion: 1 person, 25.00%
Gallbladder Disorder: 1 person, 25.00%
Diarrhea: 1 person, 25.00%
Cholecystitis Chronic (long lasting infection of gallbladder): 1 person, 25.00%
Breathing Difficulty: 1 person, 25.00%

Common conditions people have *:

Premenstrual Syndrome: 1 person, 25.00%
Premenstrual Dysphoric Disorder: 1 person, 25.00%
Pain: 1 person, 25.00%
Myelitis Transverse (a neurological condition consisting of an inflammatory process of the spinal cord): 1 person, 25.00%
Menstruation Irregular: 1 person, 25.00%
Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 1 person, 25.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 25.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 25.00%
Constipation: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Yasmin and have Quincke's disease?

Check whether Quincke's disease is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Quincke's disease and when was it recovered:

Quincke's disease in Yasmin

Expand to all the drugs that have ingredients of drospirenone; ethinyl estradiol:

Quincke's disease and drugs with ingredients of drospirenone; ethinyl estradiol

Alternative drugs to, pros and cons of Yasmin:

Yasmin (48,555 reports)

Common Yasmin side effects:

Browse all side effects of Yasmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Quincke's disease treatments and more:

Quincke's disease (16,202 reports)

COVID vaccines that are related to Quincke's disease:

Common drugs associated with Quincke's disease:

How the study uses the data?

The study uses data from the FDA. It is based on drospirenone; ethinyl estradiol (the active ingredients of Yasmin) and Yasmin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.